Provider review
PCOS Sisters review
Built around PCOS, names microdosing as an approach, and names the pharmacies that fill it.
It argues for smaller customized doses on clinical grounds rather than price, and sets itself against programs running standard protocols. The microdose is an approach inside the standard price rather than a product with its own figure.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
PCOS Sisters
From $150/mo for medication and management, no dose behind it
- Vs median
- $19/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by Strive Pharmacy and Striker Pharmacy (named on the site)
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Most sellers this site reviews treat PCOS as a line in a list of conditions. This one is built around it, and that shows in how it talks about dosing. It contrasts itself explicitly with programs that run a standard protocol, and names microdosing as one of its approaches on the reasoning that some patients simply respond better to smaller customized doses. That is a clinical argument rather than a discount, which is the right way round and rarer than it should be. It also does something concrete that most of this category avoids: it names the pharmacies that fill the prescriptions, so a reader can look them up rather than take a sentence about licensed partners on trust. Two things temper it. The microdose has no price of its own — it sits inside the standard monthly figure, so taking less does not cost less here, it costs the same. And the figure itself is a starting point with no milligram attached, so what any particular dose costs is still not answerable from the page. The oral option is described as something that may be available rather than something stocked and priced, which is a weaker promise than it first reads as.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You have PCOS and want a program built around it rather than a weight-loss plan with PCOS mentioned.
- You want a clinical case for a smaller dose rather than a cheaper tier.
- You want to know which pharmacy fills your prescription — they are named on the site.
Look elsewhere if
- You expect a smaller dose to cost less. It costs the same as the standard plan here.
- You are pricing a specific dose. The published figure is a starting point with no milligram behind it.
- You want the oral route confirmed. It is described as possibly available rather than stocked.
What it actually costs
Price as published
GLP-1 medication and management "starting at $150/month", with a PCOS evaluation "starting at $75" · ★ it names GLP-1 microdosing as one of its stated approaches — "some patients respond better to smaller, customized dosing rather than standard protocols" — and sets itself against "companies that offer standard dosing protocols" · ★ oral GLP-1 options are offered for patients uncomfortable with injections, though described as "may be available" rather than stocked · ★★ the dispensing pharmacies are NAMED on the site (Strive and Striker) rather than described as a licensed partner · the microdose is an approach inside the one published figure rather than a separately priced product, and no dose sits behind the $150
- Vs median
- $19/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. Microdosing is named as a stated approach rather than a product, and it costs what the standard plan costs — the one published figure covers GLP-1 medication and management generally. No molecule is attached to that figure, which is why nothing is readable before intake at the molecule level. Starting low here means asking for less inside the standard plan at the standard price.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Billed separately
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Names GLP-1 microdosing as a stated approach and argues for it on clinical rather than price grounds.
- Names the dispensing pharmacies on the site rather than describing a licensed partner.
- Built specifically around PCOS, including combination strategies with metformin.
Pharmacy, labs and oversight
PCOS Sisters dispenses through a Strive Pharmacy and Striker Pharmacy (named on the site) facility. No bloodwork is required before you start. A clinician review is billed separately.
Transparency check
2 of 4 published openly
What PCOS Sisters publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Most sellers on this site treat PCOS as a footnote. This one is built around it, and the difference shows in how it talks about dosing: it explicitly contrasts itself with programs that run standard protocols and names microdosing as one of its approaches, on the reasoning that some patients respond better to smaller customized doses. For a reader who came here because a standard titration did not suit them, that is the right framing rather than a marketing line. It also does something rare and concrete — it names the pharmacies that fill the prescriptions, which is a check a reader can actually run. Two limits. The microdose is an approach inside the standard price rather than a product with its own figure, so what a smaller dose costs is the same $150 as anything else, and nothing published attaches a milligram to that number. And the oral option is described as something that may be available rather than something in stock, which is a different promise from a price on a page.
The honest cons
The microdose has no price of its own — a smaller dose costs the same as a standard one.
- No dose is published behind the $150 figure, which is itself a "starting at".
- The oral option is described as possibly available rather than stocked and priced.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
PCOS Sisters is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#176 of 373
Ordered with the companies that pay us first, and PCOS Sisters is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- Oral semaglutide (Rybelsus)
- What a flat price costs at a low dose
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.